MYNZ
Mainz Biomed B.V.
NASDAQ · Healthcare · Medical - Diagnostics & Research · DE
$3.59
+0.84%Latest reported
- Last report date
- Sep 26, 2025
- EPS actual
- -$2.65
- EPS estimate
- —
- Revenue actual
- $286.7K
- Revenue estimate
- $497.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -824.8%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 26, 2025